ObsEva

$4.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.55 (+61.51%) Today

-$0.02 (-0.49%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ObsEva and other stocks, options, and ETFs commission-free!

About OBSV

ObsEva SA engages in the research and development of therapeutic treatments for woman's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet in November 2012 and is headquartered in Geneva, Switzerland. The listed name for OBSV is ObsEva SA Ordinary Shares.

CEO

Brian O'Callaghan

Employees

Headquarters

Geneva, Geneve (Geneva)

Founded

2012

Market Cap

187.48M

Price-Earnings Ratio

—

Dividend Yield

0.00

Average Volume

16.94M

High Today

$4.39

Low Today

$3.40

Open Price

$3.54

Volume

142.20M

52 Week High

$6.30

52 Week Low

$1.63

Collections

Analyst Ratings

71%

of 7 ratings

Buy

71%

Hold

14%

Sell

14%

OBSV Earnings

-$0.80

-$0.53

-$0.27

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 4, Pre-Market